1. Home
  2. REPL vs MLR Comparison

REPL vs MLR Comparison

Compare REPL & MLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REPL
  • MLR
  • Stock Information
  • Founded
  • REPL 2015
  • MLR 1990
  • Country
  • REPL United States
  • MLR United States
  • Employees
  • REPL N/A
  • MLR N/A
  • Industry
  • REPL Biotechnology: Pharmaceutical Preparations
  • MLR Construction/Ag Equipment/Trucks
  • Sector
  • REPL Health Care
  • MLR Consumer Discretionary
  • Exchange
  • REPL Nasdaq
  • MLR Nasdaq
  • Market Cap
  • REPL 578.4M
  • MLR 531.4M
  • IPO Year
  • REPL 2018
  • MLR 1994
  • Fundamental
  • Price
  • REPL $8.98
  • MLR $45.33
  • Analyst Decision
  • REPL Strong Buy
  • MLR Strong Buy
  • Analyst Count
  • REPL 6
  • MLR 1
  • Target Price
  • REPL $20.00
  • MLR $82.00
  • AVG Volume (30 Days)
  • REPL 1.6M
  • MLR 61.8K
  • Earning Date
  • REPL 05-22-2025
  • MLR 05-07-2025
  • Dividend Yield
  • REPL N/A
  • MLR 1.76%
  • EPS Growth
  • REPL N/A
  • MLR N/A
  • EPS
  • REPL N/A
  • MLR 4.69
  • Revenue
  • REPL N/A
  • MLR $1,133,280,000.00
  • Revenue This Year
  • REPL N/A
  • MLR N/A
  • Revenue Next Year
  • REPL N/A
  • MLR $18.14
  • P/E Ratio
  • REPL N/A
  • MLR $9.66
  • Revenue Growth
  • REPL N/A
  • MLR N/A
  • 52 Week Low
  • REPL $4.93
  • MLR $37.40
  • 52 Week High
  • REPL $17.00
  • MLR $78.25
  • Technical
  • Relative Strength Index (RSI)
  • REPL 53.81
  • MLR 54.13
  • Support Level
  • REPL $8.25
  • MLR $44.85
  • Resistance Level
  • REPL $9.53
  • MLR $46.17
  • Average True Range (ATR)
  • REPL 0.88
  • MLR 1.09
  • MACD
  • REPL 0.17
  • MLR -0.04
  • Stochastic Oscillator
  • REPL 71.10
  • MLR 39.70

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.

About MLR Miller Industries Inc.

Miller Industries Inc is engaged in the manufacturing of vehicle towing and recovery equipment. The company produces wreckers, car carriers, and trailer bodies under the Century, Vulcan, Challenger, Holmes, Champion, Chevron, Eagle, Titan, Jige, and Boniface brands. The products are sold in North America, Canada, and Mexico through independent distributors.

Share on Social Networks: